Vodafone Idea in Focus: Govt Cuts AGR Dues by 27% to ₹64,046 Crore – Game-Changer for Vi?

Vodafone Idea (Vi) has been battling massive financial pressures for years, with Adjusted Gross Revenue (AGR) dues hanging like a sword of Damocles. But in a major development that has put the Vodafone Idea share price firmly in the spotlight, the Department of Telecommunications (DoT) has slashed the telco’s AGR liability by nearly 27% to ₹64,046 crore as of December 31, 2025. This relief comes after a committee reassessed the earlier frozen amount of ₹87,695 crore, offering Vi much-needed breathing room and sparking fresh optimism among investors. What Exactly Happened with Vodafone Idea’s AGR Dues? The DoT formed a dedicated committee to review Vi’s AGR calculations following Supreme Court directions and earlier Cabinet approvals. The reassessment has now been finalized at ₹64,046 crore a reduction of approximately ₹23,649 crore from the previous estimate. This isn’t just a number tweak. For a company burdened with high debt and spectrum payments, this cut translates into t...

Bullish EMA Crossovers from Nifty 500! 📊 Top 15 Stocks Signaling Upward Momentum in October 2025

 

The Indian stock market humming along in early October 2025, with the Nifty 500 index hovering around 23,500 after a choppy September. Investors are scanning charts for reliable buy signals, and one classic setup keeps popping up—bullish EMA crossovers. When a shorter-term Exponential Moving Average (EMA) slices above a longer-term one, it's like a green light flashing for potential rallies. This momentum indicator, favored by traders for its sensitivity to recent price action, has been lighting up screens for several Nifty 500 constituents.

In this post, we're zeroing in on 15 standout stocks from the index that have flashed bullish EMA crossovers recently—think 20-day EMA crossing the 50-day, or even golden cross vibes with the 50-day overtaking the 200-day. These aren't random picks; they're backed by fresh technical data, rising volumes, and whispers of sector tailwinds like pharma's global push and banking's steady recovery. Whether you're a swing trader eyeing quick gains or a long-term holder building positions, these setups could offer entry points amid the broader market's 1-2% weekly uptick.

We'll break down each stock's crossover details, recent performance, and why it might climb higher. Remember, no signal is foolproof—always pair this with your risk management and perhaps a quick fundamentals check. Let's dive into the charts and uncover these hidden gems from the Nifty 500.

What Makes a Bullish EMA Crossover Tick?

Before we hit the list, a quick refresher: EMAs give more weight to newer prices, making them snappier than simple moving averages for spotting trend shifts. A bullish crossover happens when, say, the 20-day EMA vaults over the 50-day—signaling buyers are gaining steam. It's often confirmed by volume spikes and RSI above 50, filtering out noise. In 2025's volatile tape, with inflation cooling and FII inflows resuming, these crossovers have averaged 8-10% gains in the following month for Nifty 500 names. Now, onto the stars of the show.

1. RELIANCE: Energy Giant's Steady Climb

Reliance Industries, the Nifty 500 heavyweight, just notched a clean 20-day EMA crossover above the 50-day around ₹1,450 on October 15. Trading at ₹1,467 as of October 21, it's up 3.5% post-Q2 results that beat estimates with robust refining margins. Why bullish? Volumes doubled on the crossover day, and RSI at 62 screams momentum. With green energy bets paying off, target ₹1,550 in 4-6 weeks—watch for support at ₹1,416.

2. ECLERX: Tech Services on a Roll

eClerx Services lit up with a 50-day EMA crossover on October 20, pushing shares to ₹4,068 (up 4.8% in a session). This data analytics play has surged 25% YTD, fueled by AI outsourcing deals. The crossover came with a 10-day EMA flip too, and MACD flipping positive—classic buy setup. At RSI 68, it's hot but not overbought. Eye ₹4,300 if it holds ₹3,950; ideal for short swings in the IT rebound.

3. CSBBANK: Private Bank's Quiet Surge

CSB Bank triggered a bullish 10/20-day EMA cross on October 14, with shares at ₹386 (up 2.7% from supports). Q1 FY26 advances grew 29% YoY, outpacing peers, and NPAs dipped to historic lows. Volume-backed move, RSI at 58—textbook entry. As regional banks shine, ₹420 looks feasible; trail stops below ₹366 for safety.

4. PNBHOUSING: Housing Finance Revival

PNB Housing Finance saw its 50-day EMA cross the 200-day on October 18 amid a retest of ₹800 resistance—now at ₹888 (up 0.66%). Widening EMA gaps signal strength, with RSI diverging bullishly. CEO transition news aside, loan book expansion to ₹75,000 Cr supports the uptrend. Target ₹950; support at 50 EMA ₹850.

5. HLEGLAS: Industrial Equipment's Breakout

HLE Glascoat's weekly EMA crossover (20 over 50) hit on October 17, breaking a downward channel—shares at ₹655, up 5.7%. Bullish MACD and Bollinger squeeze confirm. Q1 sales up 8.7% YoY in glass-lined gear. Mildly bullish KST adds conviction; aim for ₹825, with ₹629 as stop.

6. BBTC: Diversified Play's Steady Build

Bombay Burmah Trading Corp (BBTC) flashed a 50/200-day golden cross on October 16, with shares at ₹2,944 (up from ₹2,758 lows). Tea and auto segments drove 9% sales growth. Volumes up 30%, RSI 55—poised for continuation. Target ₹3,200; hold above ₹2,800.

7. EQUITASBNK: Small Finance Momentum

Equitas Small Finance Bank's 20-day EMA crossed the 50-day on October 13, shares at ₹55 (despite Q1 blips). Retail loans up 20% YoY, and merger talks buzz. Weekly MACD bullish; target ₹65 if ₹52 holds.

8. PRSMJOHNSN: Cement's Subtle Shift

Prism Johnson (formerly Prism Cement) saw a 10-day EMA flip over 20-day on October 15, at ₹168 (up 1.76%). Q1 loss narrowed, volumes steady. Uptrend intact per seasonality; ₹185 target, support ₹148.

9. GODREJPROP: Realty's Hot Streak

Godrej Properties nailed a 50/200-day EMA cross on October 20, shares at ₹2,842 (up 15% monthly). Falling wedge breakout, MACD golden cross—realty boom fuel. RSI 65; ₹3,000+ in sight, stop ₹2,756.

10. EDELWEISS: Financials' Bounce

Edelweiss Financial's 20/50-day EMA crossover hit October 19, at ₹118 (up from ₹73 lows). Q1 sales jumped 750% YoY on asset recovery. Slightly bullish sentiment; target ₹130, trail below ₹114.

11. BIOCON: Pharma Powerhouse Awakens

Biocon's weekly EMA crossover (50 over 200) on October 17, shares at ₹362 (above 200 EMA). Biosimilars pipeline glows, RSI 60. Consolidation breakout; ₹400 target if ₹350 holds.

12. LAURUSLABS: Labs' Bullish Channel

Laurus Labs broke with a 21/50-day EMA cross on October 18, at ₹924 (near 52-week high). VCP pattern, volumes surging—ARV demand up. Target ₹950+; support ₹885.

13. J&KBANK: Regional Bank's Edge

J&K Bank's 50-day EMA crossed 200-day on October 14, shares at ₹101 (up 0.88%). Q1 income up 10%, low NPAs. FII inflows; ₹115 target, low at ₹82.

14. DRREDDY: Global Pharma Nod

Dr. Reddy's EMA setup flipped bullish on October 20 (falling wedge cross), at ₹1,256. EMA panel greenlit biosimilar—US nod pending. Target ₹1,350; RSI bullish.

15. SUNPHARMA: Sector Leader's Rally

Sun Pharma's MACD/EMA crossover on October 10, shares at ₹1,669 (up 6% post-week). Inverted H&S breakout, Q1 EPS ₹43. Target ₹1,800; hold above ₹1,548.

Wrapping Up: Ride the Momentum Wisely

These 15 Nifty 500 stocks aren't just flashing EMA crossovers—they're riding sector waves from pharma exports to banking digitization. With the index eyeing 25,000 by Diwali, early entries here could yield 10-20% pops, but volatility lurks (hello, US elections). Diversify, use 1-2% stops, and track volumes for confirmation. What's your top pick from this list? Drop a comment below—happy trading, and may your portfolio crossover into profits!

Disclaimer: This isn't financial advice. Markets move fast; DYOR and consult pros.

Comments